Evelo Biosciences, Inc. announced that on May 31, 2022, Luca Scavo delivered his resignation as the Chief Financial Officer of the “Company, effective June 3, 2022, to pursue another professional opportunity. The Company will conduct a search for Mr. Scavo's replacement and, pending the appointment of such replacement, intends to designate Balkrishan “Simba” Gill, Ph.D., the Chief Executive Officer and President of the Company, as the Company's principal financial officer ad interim.